Reply on behalf of the ERS/EULAR task force for connective tissue disease-associated interstitial lung disease

<title>Extract</title> We appreciate the interest and engagement from J.R. Davidsen and co-workers regarding the recently published European Respiratory Society (ERS)/European Alliance of Associations for Rheumatology (EULAR) clinical practice guidelines for connective tissue disease-associated interstitial lung disease (CTD-ILD) [1, 2]. We recognise the rapidly evolving evidence landscape for screening tools in rheumatoid arthritis-associated ILD (RA-ILD).